- Round ID
- FR-00500
- Stage
- Series C
- Round name
- Series C
- Amount
- $55M
Dated funding evidence
Paragraf
Series C · $55M · 2025-08-25
Reported round$55MSeries C
- Disclosure date
- 2025-08-25
- Reported currency
- USD
- Companies House
- 09889431
- Evidence sources
- 2
Company
ParagrafCH 098894312025-08-25Series C$55M
Resolved investor records
Amadeus Capital PartnersInvestorBritish Patient CapitalInvestorCambridge EnterpriseInvestorIQ CapitalInvestorMolten VenturesInvestorNew Science VenturesInvestorParkwalk AdvisorsInvestor
4 additional source-listed names are retained in the record fields below but not linked without an exact canonical match.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Mubadala Capital ($35M for 12.8% stake)
- Other investors
- Amadeus Capital Partners, British Patient Capital, Cambridge Enterprise, IQ Capital, IQT, Martlet Capital, Molten Ventures, New Science Ventures, Openfield Capital, Parkwalk Advisors
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.